Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
International Journal of Nanomedicine|February 28, 2020
The Safety and Exploration of the Pharmacokinetics of Intrapleural Liposomal CurcuminAshleigh Hocking, Sara Tommasi, Peter Sordillo, et al.
Ageing Research Reviews|November 25, 2023
Circulating arginine metabolites in Alzheimer's disease and vascular dementia: A systematic review and meta-analysisAngelo Zinellu, Sara Tommasi, Stefania Sedda, et al.
Heliyon|March 22, 2024
Arginine metabolomics in mood disordersAngelo Zinellu, Sara Tommasi, Stefania Sedda, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 7, 2019
Small molecule inhibition of DDAH1 significantly attenuates triple negative breast cancer cell vasculogenic mimicry in vitroJulie-Ann Hulin, Sara Tommasi, David Elliot, et al.
Molecules (Basel, Switzerland)|May 18, 2016
Inhibitors of the Hydrolytic Enzyme Dimethylarginine Dimethylaminohydrolase (DDAH): Discovery, Synthesis and DevelopmentRhys B Murphy, Sara Tommasi, Benjamin C Lewis, et al.
Translational Psychiatry|October 16, 2024
A systematic review and meta-analysis of nitric oxide-associated arginine metabolites in schizophreniaAngelo Zinellu, Sara Tommasi, Ciriaco Carru, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 27, 2025
Current knowledge on the mechanisms underpinning vasculogenic mimicry in triple negative breast cancer and the emerging role of nitric oxideBelete Kassa Alemu, Sara Tommasi, Julie-Ann Hulin, et al.
RSC Advances|March 25, 2024
Recent advances in DDAH1 inhibitor design and discovery: insights from structure-activity relationships and X-ray crystal structuresAnthony J Doman, Michael V Perkins, Sara Tommasi, et al.
Molecules (Basel, Switzerland)|February 15, 2022
Pharmacokinetic Characterization of the DDAH1 Inhibitors ZST316 and ZST152 in Mice Using a HPLC-MS/MS MethodArduino A Mangoni, Tommaso Ceruti, Roberta Frapolli, et al.
Drugs in Context|November 22, 2018
Repurposing existing drugs for cardiovascular risk management: a focus on methotrexateArduino A Mangoni, Sara Tommasi, Angelo Zinellu, et al.
Pageof 3